Further response to my query re , head and neck , type meeting with FDA, from Deanne Miller. “Regarding your question about the Head and Neck trial, I can confirm that meetings pertaining to future registrational trial designs (i.e. exploration of potential paths for approval, which is what we had advised we had requested the FDA meeting for regarding our CPS<1 head and neck results) are typically classified as Type C meetings.”
IMM Price at posting:
24.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)